Skip to content

Effect of Kinetic Control Exercise on Shoulder Dysfunction Post Mastectomy

Effect of Kinetic Control Exercise on Shoulder Dysfunction Post Mastectomy

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07023913
Enrollment
60
Registered
2025-06-17
Start date
2025-06-15
Completion date
2025-10-15
Last updated
2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysfunction, Kinetic Control, Mastectomy, Shoulder

Brief summary

The purpose of this study is to evaluate the effect of kinetic control exercises on shoulder dysfunction in post-mastectomy.

Detailed description

This study holds significant importance for clinical practice, patient care, and research. * Clinical Practice: It provides a potential framework for physical therapists to design targeted and effective interventions for shoulder dysfunction in post-mastectomy patients. * Patient Care: Improved rehabilitation outcomes can enhance patients' physical functionality, independence, and overall quality of life, addressing a critical gap in post-operative recovery. * Research Advancement: By contributing to the limited body of literature on kinetic control in this context, the study can stimulate further research and innovation in rehabilitative care for breast cancer survivors.

Interventions

Kinetic Control exercises consist of 45-minute sessions, with 3 sessions per week for 8 weeks. The framework for testing and rehabilitation includes initial assessment, rehabilitation before failure, and retesting the same position. Biofeedback measures scapular retraction, and biofeedback pressure training assesses and improves scapular stabilizer control by monitoring pressure changes during specific movements.

OTHERtraditional treatment

traditional therapy inform of stretching and strengthening exercise as shoulder roll, arm circle, wall climb, back climb and hand behind neck. Patients will receive 3 sessions per week for 8 weeks, the time of session is 45 - 60 min according to patient ability

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

The subject selection will be according to the following criteria: * Age from 40 to 50 years. * All patients have no diabetes or blood problems. * All patients enrolled to the study will have their informed consent.

Exclusion criteria

The potential participants will be excluded if they meet one of the following criteria: * Age less than 40 or more 50 years. * Diabetes mellitus. * Subjects with lymphedema * Subjects suffering from active malignant tumors. * Subjects treated with skin graft. * Subjects with Mental illness. * Subjects with skin diseases * Subjects with any previous cause for shoulder dysfunction

Design outcomes

Primary

MeasureTime frameDescription
assessment of change of range of motionat baseline and after 8 weeksPatients will be seated with their affected limb relaxed, and their goniometer will measure their resting position and active range. They will measure shoulder abduction and flexion, which are rarely affected by day-to-day activities, and external shoulder rotation.

Secondary

MeasureTime frameDescription
assessment of ability to maintain controlled shoulder movements while stabilizing the scapular and shoulderat baseline and after 8 weeksit is a series of tests to assess kinetic control, including shoulder flexion, scapular retraction, and isometric holds. The tests focus on maintaining consistent pressure, detecting compensatory patterns, and evaluating fatigue. The tests also include a scapular stabilization test and a shoulder flexion stability test, which measure muscle activation patterns and stability.

Countries

Egypt

Contacts

Primary ContactAlaa Tarek Mostafa Elnawawy, physical therapist
alaatarekmostafa@gmail.com+201005730916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026